Office of Public Health Studies, University of Hawai'i at Mānoa, Honolulu, Hawaii, USA.
Metab Syndr Relat Disord. 2021 Aug;19(6):347-351. doi: 10.1089/met.2020.0090. Epub 2021 Mar 1.
Accurate prevalence measurement and diagnosis to prevent type 2 diabetes mellitus and cardiovascular disease cannot occur without consistent diagnostic criteria that can be applied to varying populations. The objective of this study was to determine the prevalence of metabolic syndrome in Caucasian, Filipino, Native Hawaiian, and Japanese populations utilizing different definitions. This study utilized cross-sectional study data from the Native Hawaiian/Multiethnic Health Research Project, collected from a population living in Kohala, Hawai'i. The National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPII), International Diabetes Federation (IDF), and World Health Organization (WHO) definitions were utilized, and each of the 1452 participants were evaluated on the criteria for metabolic syndrome based on all three definitions. Additionally, the average biomarker values associated with the diagnosis were taken for each ethnic group represented in the study and compared with Caucasians. The overall prevalence of metabolic syndrome in this population varied from 22.31% to 39.05% using the different definitions. Ethnic disparities also occur, implying that certain populations are more prone to having severe abnormalities than others-shown when comparing the average biomarker values associated with metabolic syndrome diagnosis. Of all ethnic groups included in the study, Caucasians had the lowest prevalence of metabolic syndrome, while part-Hawaiians had the highest prevalence. Additionally, within the same ethnic group, the definitions yielded varying prevalence values. This implies that discrepancies exist among the criteria alone. Implications of this study revolve around not only the correct definition to apply to the population being studied but also the most accurate way to detect certain biomarker abnormalities to accurately assess the prevalence of metabolic syndrome in a multiethnic population.
要准确测量和诊断 2 型糖尿病和心血管疾病的患病率,如果没有适用于不同人群的一致诊断标准,就无法实现。本研究的目的是利用不同的定义来确定白种人、菲律宾人、夏威夷原住民和日本人中代谢综合征的患病率。本研究利用了来自生活在夏威夷科哈拉的人群的夏威夷原住民/多种族健康研究项目的横断面研究数据。使用了国家胆固醇教育计划-成人治疗小组 III(NCEP-ATPIII)、国际糖尿病联合会(IDF)和世界卫生组织(WHO)的定义,根据所有三个定义,对 1452 名参与者中的每一位进行了代谢综合征标准的评估。此外,还对研究中代表的每个种族群体的与诊断相关的平均生物标志物值进行了评估,并与白种人进行了比较。使用不同的定义,该人群代谢综合征的总体患病率从 22.31%到 39.05%不等。种族差异也存在,这意味着某些人群比其他人群更容易出现严重异常——当比较与代谢综合征诊断相关的平均生物标志物值时就可以看出这一点。在研究中包括的所有种族群体中,白种人患代谢综合征的比例最低,而部分夏威夷人最高。此外,在同一族裔群体中,不同的定义产生了不同的患病率值。这表明仅在标准方面就存在差异。这项研究的意义不仅在于应用于研究人群的正确定义,还在于检测某些生物标志物异常的最准确方法,以便准确评估多种族人群中代谢综合征的患病率。